Global Oncolytic Virus Market Size, Covid-19 Impact Analysis, key Insights Based on Product Type, End-use and Regional Demand till 2025
- BMR3856524
- 124 Pages
- May 2020
- Healthcare
This report focuses on Oncolytic Virus volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Oncolytic Virus market size by analyzing historical data and future prospect.
Regionally, this report categorizes the sales of Oncolytic Virus in North America, Europe, China, Australia, etc.
For the manufacturers covered, this report analyses the Oncolytic Virus manufacturing sites, sales, ex-factory price, revenue and market share for each company.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the Oncolytic Virus market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Oncolytic Virus industry.
By Company
Amgen
Shanghai Sunway Biotech
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Segment by Type
Imlygic
Oncorine
Others
Segment by Application
Melanoma
Other Cancers
By Region
North America
Europe
China
Australia
RoW
1.1 Definition of Oncolytic Virus 1
1.2 Oncolytic Virus Segment by Type 2
1.2.1 Global Oncolytic Virus Sales Growth Rate Comparison by Type (2020-2026) 2
1.2.2 Imlygic 3
1.2.3 Oncorine 4
1.3 Oncolytic Virus Segment by Application 5
1.3.1 Global Oncolytic Virus Sales Comparison by Application (2020-2026) 5
1.3.2 Melanoma 6
1.3.3 Other Cancers 7
1.4 Global Oncolytic Virus Overall Market: 2015 VS 2020 VS 2026 8
1.4.1 Global Oncolytic Virus Revenue (2015-2026) 9
1.4.2 Global Oncolytic Virus Sales (2015-2026) 11
1.4.3 North America Oncolytic Virus Status and Prospect (2015-2026) 12
1.4.4 Europe Oncolytic Virus Status and Prospect (2015-2026) 12
1.4.5 China Oncolytic Virus Status and Prospect (2015-2026) 13
1.4.6 Australia Oncolytic Virus Status and Prospect (2015-2026) 13
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 14
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 14
1.5.2 Covid-19 Impact: Commodity Prices Indices 21
1.5.3 Covid-19 Impact: Global Major Government Policy 26
2 MANUFACTURING COST STRUCTURE ANALYSIS 31
2.1 Raw Material and Suppliers 31
2.1.1 Clinical Phase Costs 33
2.1.2 Capitalized Costs 33
2.2 Proportion of Manufacturing Cost Structure 35
2.2.1 Raw Materials 35
2.2.2 Raw Materials 36
2.2.3 Labor Cost 36
2.2.4 Other Costs Analysis 42
2.2.5 Manufacturing Expenses 46
2.3 Manufacturing Process Analysis of Oncolytic Virus 47
2.4 Industry Chain Structure of Oncolytic Virus 48
3 DEVELOPMENT AND MANUFACTURING PLANTS ANALYSIS OF ONCOLYTIC VIRUS 49
3.1 Top Manufacturers Headquarters, Rank by Oncolytic Virus Sales 49
3.2 Global Oncolytic Virus Manufacturers Sales Regions and Commercial Production Date 49
3.3 Global Oncolytic Virus Manufacturers Headquarters and Established Date 49
3.4 Major Manufacturers Oncolytic Virus Product Offered 50
3.5 Global Oncolytic Virus Therapy Pipeline of Key Players/Manufacturers 50
3.6 Recent Development and Expansion Plans 51
4 KEY FIGURES OF MAJOR MANUFACTURERS 53
4.1 Global Top Manufacturers Oncolytic Virus Sales Analysis 53
4.2 Global Top Manufacturers Oncolytic Virus Revenue Analysis 54
4.3 Global Top Manufacturers Oncolytic Virus Price Analysis 56
5 ONCOLYTIC VIRUS REGIONAL MARKET ANALYSIS 57
5.1 Oncolytic Virus Sales by Regions 57
5.1.1 Global Oncolytic Virus Sales by Regions (2015-2020) 57
5.1.2 Global Oncolytic Virus Revenue by Regions 58
5.2 North America Oncolytic Virus Market Analysis 60
5.2.1 North America Oncolytic Virus Sales 60
5.2.2 North America Oncolytic Virus Revenue 60
5.2.3 Key Players in North America 61
5.3 Europe Oncolytic Virus Market Analysis 61
5.3.1 Europe Oncolytic Virus Sales 61
5.3.2 Europe Oncolytic Virus Revenue 62
5.3.3 Key Players in Europe 62
5.4 China Oncolytic Virus Market Analysis 63
5.4.1 China Oncolytic Virus Sales 63
5.4.2 China Oncolytic Virus Revenue 63
5.4.3 Key Players in China 64
5.5 Australia Oncolytic Virus Market Analysis 64
5.5.1 Australia Oncolytic Virus Sales 64
5.5.2 Australia Oncolytic Virus Revenue 65
5.5.3 Key Players in Australia 65
6 ONCOLYTIC VIRUS SEGMENT MARKET ANALYSIS (BY TYPE) 66
6.1 Global Oncolytic Virus Sales by Type 66
6.2 Global Oncolytic Virus Revenue by Type 67
6.3 Oncolytic Virus Price by Type 69
7 ONCOLYTIC VIRUS SEGMENT MARKET ANALYSIS (BY APPLICATION) 70
7.1 Overview 70
7.2 Global Oncolytic Virus Sales Market Share by Application (2015-2020) 70
8 ANALYSIS OF ONCOLYTIC VIRUS INDUSTRY KEY MANUFACTURERS 72
8.1 Amgen 72
8.1.1 Company Profile 72
8.1.2 Product Information 73
8.1.3 Sales, Price, Revenue and Gross Margin 73
8.2 Shanghai Sunway Biotech 73
8.2.1 Company Profile 73
8.2.2 Product Information 75
8.2.3 Sales, Price, Revenue and Gross Margin 75
8.3 Oncolytics Biotech 76
8.3.1 Company Profile 76
8.3.2 Product Information 77
8.4 Viralytics 77
8.4.1 Company Profile 77
8.4.2 Product Information 78
8.5 Transgene SA 79
8.5.1 Company Profile 79
8.5.2 Product Information 80
8.6 Oncolys BioPharma 81
8.6.1 Company Profile 81
8.6.2 Product Information 82
8.7 Targovax 83
8.7.1 Company Profile 83
8.7.2 Product Information 84
8.8 PsiOxus Therapeutics 85
8.8.1 Company Profile 85
8.8.2 Product Information 86
8.9 SillaJen Biotherapeutics 87
8.9.1 Company Profile 87
8.9.2 Product Information 87
8.10 Sorrento Therapeutics 89
8.10.1 Company Profile 89
8.10.2 Product Information 90
8.11 Lokon Pharma 91
8.11.1 Company Profile 91
8.11.2 Product Information 92
8.12 Genelux Corporation 93
8.12.1 Company Profile 93
8.12.2 Product Information 94
8.13 Vyriad 94
8.13.1 Company Profile 94
8.13.2 Product Information 96
8.14 TILT Biotherapeutics 96
8.14.1 Company Profile 96
8.14.2 Product Information 97
8.15 Cold Genesys 98
8.15.1 Company Profile 98
8.15.2 Product Information 99
9 DEVELOPMENT TREND OF ANALYSIS OF ONCOLYTIC VIRUS MARKET 101
9.1 Global Oncolytic Virus Market Size (Volume and Value) Forecast 2021-2026 101
9.2 Oncolytic Virus Regional Market Trend 102
9.2.1 North America Oncolytic Virus Forecast 2021-2026 102
9.2.2 Europe Oncolytic Virus Forecast 2021-2026 103
9.2.3 China Oncolytic Virus Forecast 2021-2026 103
9.2.4 Australia Oncolytic Virus Forecast 2021-2026 104
9.3 Oncolytic Virus Market Trend (Product Type) 104
9.4 Oncolytic Virus Market Trend (Application) 105
10 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 106
10.1 Marketing Channel 106
10.1.1 Direct Channels 106
10.1.2 Indirect Channels 106
10.2 Oncolytic Virus Distributors List 107
10.3 Oncolytic Virus Customers 109
11 MARKET DYNAMICS 112
11.1 Market Trends 112
11.2 Opportunities and Drivers 112
11.3 Challenges 112
11.4 Porter's Five Forces Analysis 113
12 CONCLUSION 115
13 APPENDIX 116
13.1 Methodology/Research Approach 116
13.1.1 Research Programs/Design 116
13.1.2 Market Size Estimation 117
13.1.3 Market Breakdown and Data Triangulation 118
13.2 Data Source 119
13.2.1 Secondary Sources 119
13.2.2 Primary Sources 120
13.3 Author List 122
13.4 Disclaimer 122
Table 2. Global Oncolytic Virus Sales (K Unit) Comparison by Application (2020-2026) 5
Table 3. Global Oncolytic Virus Market Size by Region in US$ Million: 2015 VS 2020 VS 2026 8
Table 4. Overview of the World Economic Outlook Projections 16
Table 5. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) 17
Table 6. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) 18
Table 7. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) 19
Table 8. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) 20
Table 9. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) 21
Table 10. Covid-19 Impact: Global Major Government Policy 26
Table 11. Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound 33
Table 12. Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 34
Table 13. Oncolytic Virus Sales Rank and sales of Key Players 49
Table 14. Global Oncolytic Virus Manufacturers Sales Regions and Commercial Production Date 49
Table 15. Manufacturers Oncolytic Virus Therapy Manufacturers Headquarters and Established Date 49
Table 16. Oncolytic Virus Major Manufacturers Oncolytic Virus Product Offered 50
Table 17. Global Oncolytic Virus Therapy Pipeline of Key Players/Manufacturers 50
Table 18. Recent Development and Expansion Plans in Future 51
Table 19. Global Oncolytic Virus Manufacturers Covered in This report: Sales, Revenue and Market Share in 2019 53
Table 20. Global Oncolytic Virus Sales (K Unit) of Major Manufacturers (2019-2020) 53
Table 21. Oncolytic Virus Sales Market Share of Major Manufacturers (2019-2020) 54
Table 22. Global Oncolytic Virus Revenue (US$ Million) of Major Manufacturers (2019-2020) 55
Table 23. Oncolytic Virus Revenue Market Share of Major Manufacturers (2019-2020) 55
Table 24. Global Oncolytic Virus Average Price of Major Manufacturers (2019-2020) 56
Table 25. Global Oncolytic Virus Sales by Regions (2015-2020) (K Unit) 57
Table 26. Global Oncolytic Virus Sales Market Share by Regions (2015-2020) 57
Table 27. Global Oncolytic Virus Revenue by Regions (2015-2020) (US$ Million) 58
Table 28. Global Oncolytic Virus Revenue Market Share by Regions (2015-2020) 58
Table 29. Key Oncolytic Virus Players in North America 61
Table 30. Key Oncolytic Virus Players in Europe 62
Table 31. Key Oncolytic Virus Players in China 64
Table 32. Key Oncolytic Virus Players in Australia 65
Table 33. Global Oncolytic Virus Sales by Type (2015-2020) (K Unit) 66
Table 34. Global Oncolytic Virus Sales Share by Type (2015-2020) 66
Table 35. Global Oncolytic Virus Revenue by Type (2015-2020) (US$ Million) 67
Table 36. Global Oncolytic Virus Revenue Share by Type (2015-2020) 68
Table 37. Oncolytic Virus Price by Type (2015-2020) 69
Table 38. Global Oncolytic Virus Sales by Application (2015-2020) (K Unit) 70
Table 39. Global Oncolytic Virus Sales Share by Application (2015-2020) 71
Table 40. Amgen Company Profile 72
Table 41. Oncolytic Virus Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2019-2020 73
Table 42. Shanghai Sunway Biotech Company Profile 73
Table 43. Oncolytic Virus Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Shanghai Sunway Biotech 2019-2020 75
Table 44. Oncolytics Biotech Company Profile 76
Table 45. Viralytics Company Profile 77
Table 46. Transgene SA Company Profile 79
Table 47. Oncolys BioPharma Company Profile 81
Table 48. Targovax Company Profile 83
Table 49. PsiOxus Therapeutics Company Profile 85
Table 50. SillaJen Biotherapeutics Company Profile 87
Table 51. Sorrento Therapeutics Company Profile 89
Table 52. Lokon Pharma Company Profile 91
Table 53. Genelux Corporation Company Profile 93
Table 54. Vyriad Company Profile 94
Table 55. TILT Biotherapeutics Company Profile 96
Table 56. Cold Genesys Company Profile 98
Table 57. Global Sales (K Unit) of Oncolytic Virus by Type (2021-2026) 104
Table 58. Global Sales Market Share of Oncolytic Virus by Type (2021-2026) 104
Table 59. Global Sales (K Unit) of Oncolytic Virus by Application (2021-2026) 105
Table 60. Global Sales Market Share of Oncolytic Virus by Application (2021-2026) 105
Table 61. Oncolytic Virus Distributors List 107
Table 62. Oncolytic Virus Customers List 109
Table 63. Market Key Trends 112
Table 64. Key Opportunities and Drivers: Impact Analysis (2021-2026) 112
Table 65. Key Challenges 113
Table 66. Research Programs/Design for This Report 116
Table 67. Key Data Information from Secondary Sources 119
Table 68. Key Data Information from Primary Sources 121
Figure 1. Picture of Oncolytic Virus 1
Figure 2. Milestones of Oncolytic Virus Therapy Development. 2
Figure 3. Global Oncolytic Virus Market Share by Type in 2020 3
Figure 4. Global Oncolytic Virus Market Share by Type in 2026 3
Figure 5. Imlygic Product Picture 4
Figure 6. Oncorine Product Picture 5
Figure 7. Global Oncolytic Virus Market Share by Application in 2020 6
Figure 8. Global Oncolytic Virus Market Share by Application in 2026 6
Figure 9. Melanoma 7
Figure 10. Other Cancers 7
Figure 11. Global Oncolytic Virus Market Share Scenario by Region in Percentage in 2020 9
Figure 12. Global Oncolytic Virus Market Share Scenario by Region in Percentage in 2026 9
Figure 13. Global Oncolytic Virus Market Size (Value), (US$ Million), 2015 VS 2020 VS 2026 10
Figure 14. Global Oncolytic Virus Revenue (US$ Million) (2015-2026) 11
Figure 15. Global Oncolytic Virus Sales (K Unit) (2015-2026) 11
Figure 16. North America Oncolytic Virus Revenue (US$ Million) Growth Rate (2015-2026) 12
Figure 17. Europe Oncolytic Virus Revenue (US$ Million) Growth Rate (2015-2026) 12
Figure 18. China Oncolytic Virus Revenue (US$ Million) Growth Rate (2015-2026) 13
Figure 19. Australia Oncolytic Virus Revenue (US$ Million) Growth Rate (2015-2026) 13
Figure 20. Commodity Prices-Metals Price Indices 22
Figure 21. Commodity Prices- Precious Metal Price Indices 23
Figure 22. Commodity Prices- Agricultural Raw Material Price Indices 23
Figure 23. Commodity Prices- Food and Beverage Price Indices 24
Figure 24. Commodity Prices- Fertilizer Price Indices 24
Figure 25. Commodity Prices- Energy Price Indices 25
Figure 26. G20+: Economic Policy Responses to COVID-19 26
Figure 27. Typical Phases from Research to the Market for a Drug Candidate 32
Figure 28. Timeline and Development Stages for a Pharmaceutical Products (Industry Average) 32
Figure 29. Manufacturing Cost Structure of New Drugs 35
Figure 30. Assessment of API Manufacturing Cost By Region 36
Figure 31. Manufacturing Process Analysis of Oncolytic Virus 47
Figure 32. Industry Chain Structure of Oncolytic Virus 48
Figure 33. Oncolytic Virus Sales Share by Manufacturers in 2019 54
Figure 34. Oncolytic Virus Revenue Share by Manufacturers in 2019 55
Figure 35. Global Oncolytic Virus Sales Market Share by Regions in 2019 58
Figure 36. Global Oncolytic Virus Revenue Market Share by Regions in 2019 59
Figure 37. North America Oncolytic Virus Sales Growth Rate 2015-2020 (K Unit) 60
Figure 38. North America Oncolytic Virus Revenue Growth Rate 2015-2020 (US$ Million) 60
Figure 39. Europe Oncolytic Virus Sales Growth Rate 2015-2020 (K Unit) 61
Figure 40. Europe Oncolytic Virus Revenue Growth Rate 2015-2020 (US$ Million) 62
Figure 41. China Oncolytic Virus Sales Growth Rate 2015-2020 (K Unit) 63
Figure 42. China Oncolytic Virus Revenue Growth Rate 2015-2020 (US$ Million) 63
Figure 43. Australia Oncolytic Virus Sales Growth Rate 2015-2020 (K Unit) 64
Figure 44. Australia Oncolytic Virus Revenue Growth Rate 2015-2020 (US$ Million) 65
Figure 45. Global Oncolytic Virus Sales Market Share by Type (2015-2020) 67
Figure 46. Global Oncolytic Virus Sales Market Share by Type in 2019 67
Figure 47. Global Oncolytic Virus Revenue Market Share by Type (2015-2020) 68
Figure 48. Global Oncolytic Virus Revenue Market Share by Type in 2019 69
Figure 49. Global Oncolytic Virus Sales Market Share by Application (2015-2020) (K Unit) 70
Figure 50. Global Oncolytic Virus Sales Market Share by Application in 2019 71
Figure 51. Oncolytic Virus Product Picture of Amgen 73
Figure 52. Oncolytic Virus Product Picture of Shanghai Sunway Biotech 75
Figure 53. Oncolytic Virus Product Picture of Oncolytics Biotech 77
Figure 54. Oncolytic Virus Product Picture of Viralytics 79
Figure 55. Oncolytic Virus Product Picture of Transgene SA 80
Figure 56. Oncolytic Virus Product Picture of Oncolys BioPharma 82
Figure 57. Oncolytic Virus Product Picture of Targovax 84
Figure 58. Oncolytic Virus Product Picture of PsiOxus Therapeutics 86
Figure 59. Oncolytic Virus Product Picture of SillaJen Biotherapeutics 88
Figure 60. Oncolytic Virus Product Picture of Sorrento Therapeutics 91
Figure 61. Oncolytic Virus Product Picture of Lokon Pharma 92
Figure 62. Oncolytic Virus Product Picture of Genelux Corporation 94
Figure 63. Oncolytic Virus Product Picture of Vyriad 96
Figure 64. Oncolytic Virus Product Picture of TILT Biotherapeutics 97
Figure 65. Oncolytic Virus Product Picture of Cold Genesys 99
Figure 66. Global Oncolytic Virus Sales (K Unit) Growth Rate Forecast 2021-2026 101
Figure 67. Global Oncolytic Virus Revenue (US$ Million) Growth Rate Forecast 2021-2026 102
Figure 68. North America Oncolytic Virus Sales Growth Rate Forecast 2021-2026 (K Unit) 102
Figure 69. Europe Oncolytic Virus Sales Growth Rate Forecast 2021-2026 (K Unit) 103
Figure 70. China Oncolytic Virus Sales Growth Rate Forecast 2021-2026 (K Unit) 103
Figure 71. Australia Oncolytic Virus Sales Growth Rate Forecast 2021-2026 (K Unit) 104
Figure 72. Channels of Distribution 107
Figure 73. Distributors Profiles 109
Figure 74. Porter's Five Forces Analysis 114
Figure 75. Bottom-up and Top-down Approaches for This Report 118
Figure 76. Data Triangulation 119
Figure 77. Key Executives Interviewed 121
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
